The ALK gene may fuse with multiple partner genes, such as TPM3/4, GCC2, TRAF3, EML4, and THBS1, which could be one of the key mechanisms underlying the development of IMT (35–37). The gene discussed is ALK; the disease is inflammatory myofibroblastic tumor.